{"schema_version":"secwatch.filing_event.v1","accession":"0000012208-23-000054","form_type":"8-K","ticker":"BIO","cik":"0000012208","company_name":"BIO-RAD LABORATORIES, INC.","filed_at":"2023-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.186528+00:00","generated_at":"2026-06-14T07:11:05.752543+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bio-Rad completes $650M share repurchase program; plans additional authorization in Q3","bullets":["Q2-to-date repurchased $207.4M of Class A common stock, 549,863 shares at avg $377.20.","Aggregate repurchases reach the $650M limit authorized by Board in Nov 2017, July 2020, and July 2022.","Management intends to seek Board approval for additional repurchase authority in Q3 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000012208-23-000054","json":"https://secwatch.observer/filing/0000012208-23-000054.json","markdown":"https://secwatch.observer/filing/0000012208-23-000054.md","text":"https://secwatch.observer/filing/0000012208-23-000054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12208/000001220823000054/0000012208-23-000054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12208/000001220823000054/bio-20230605.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T07:11:05.752543+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}